Results
1
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
1 companies
Novo Nordisk
Market Cap: DKK 1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 294.70
7D
-6.5%
1Y
-61.9%